Elevance Health SG&A increased by 16.9% to $6.33B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 19.4%, from $5.30B to $6.33B. Over 4 years (FY 2021 to FY 2025), SG&A shows an upward trend with a 7.2% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementIncome Statement
SectionOperating Expenses
CategoryEfficiency
SignalLower is better
VolatilityStable
First reportedQ4 2013
Last reportedQ4 2025
How to read this metric
Increases may indicate aggressive marketing or expansion, while decreases often reflect cost-cutting measures or improved corporate efficiency.
Detailed definition
The sum of all direct and indirect selling expenses and all general and administrative expenses of a company. This inclu...
Peer comparison
Used to assess the 'leaness' of a company's corporate structure relative to its peers.
Metric ID:
is_selling_general_and_administrativeHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.82B | $3.95B | $4.22B | $4.34B | $4.27B | $4.51B | $4.56B | $4.80B | $4.82B | $5.47B | $5.00B | $4.89B | $5.07B | $5.27B | $4.80B | $5.30B | $5.00B | $5.27B | $5.42B | $6.33B |
| QoQ Change | — | +3.3% | +7.0% | +2.8% | -1.7% | +5.7% | +1.1% | +5.2% | +0.4% | +13.5% | -8.6% | -2.3% | +3.7% | +4.0% | -8.8% | +10.3% | -5.7% | +5.5% | +2.7% | +16.9% |
| YoY Change | — | — | — | — | +11.7% | +14.4% | +8.1% | +10.6% | +12.9% | +21.2% | +9.6% | +1.8% | +5.1% | -3.7% | -3.9% | +8.5% | -1.4% | +0.1% | +12.7% | +19.4% |
Range$3.82B – $6.33B
CAGR+11.2%
Avg YoY Growth+7.9%
Median YoY Growth+9.0%
Current Streak3 quarters growth
Business Segments
| Segment | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|
| Health Benefits | $4.82B | $4.54B | $4.80B | $4.89B | $4.88B |
| Corporate & Other | $295.00M | $295.00M | $226.00M | $0.00 | $1.12B |
| Carelon Services | $726.00M | $751.00M | $756.00M | $840.00M | $810.00M |
| CarelonRx | $230.00M | $223.00M | $232.00M | $220.00M | $188.00M |
| Total | $5.30B | $5.00B | $5.27B | $5.42B | $6.33B |
SG&A at Other Companies
Frequently Asked Questions
- What is Elevance Health's sg&a?
- Elevance Health (ELV) reported sg&a of $6.33B in Q1 2026.
- How has Elevance Health's sg&a changed year-over-year?
- Elevance Health's sg&a increased by 19.4% year-over-year, from $5.30B to $6.33B.
- What is the long-term trend for Elevance Health's sg&a?
- Over 4 years (2021 to 2025), Elevance Health's sg&a has grown at a 7.2% compound annual growth rate (CAGR), from $15.91B to $20.98B.
- What does sg&a mean?
- The day-to-day costs of running the business and marketing its products.